Literature DB >> 15786457

Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity.

Natasa Jokic1, Jose-Luis Gonzalez de Aguilar, Pierre-François Pradat, Luc Dupuis, Andoni Echaniz-Laguna, André Muller, Odile Dubourg, Danielle Seilhean, Jean-Jacques Hauw, Jean-Philippe Loeffler, Vincent Meininger.   

Abstract

Nogo, a protein inhibiting axonal regeneration, exhibits a characteristic isoform-specific pattern of expression in skeletal muscle of transgenic mice and patients with amyotrophic lateral sclerosis. Here, the increased levels of Nogo-A or Nogo-B in muscle biopsies of 15 amyotrophic lateral sclerosis patients significantly correlated with the severity of clinical disability and with the degree of muscle fiber atrophy. Nogo-A immunoreactivity was observed selectively in atrophic slow-twitch type I fibers. These results suggest that Nogo expression in muscle is a marker of amyotrophic lateral sclerosis severity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15786457     DOI: 10.1002/ana.20420

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  37 in total

1.  Selective temporal and regional alterations of Nogo-A and small proline-rich repeat protein 1A (SPRR1A) but not Nogo-66 receptor (NgR) occur following traumatic brain injury in the rat.

Authors:  Niklas Marklund; Carl T Fulp; Saori Shimizu; Rishi Puri; Asenia McMillan; Stephen M Strittmatter; Tracy K McIntosh
Journal:  Exp Neurol       Date:  2006-01       Impact factor: 5.330

2.  Nogo-A marks motor neuron disease.

Authors:  Noam Y Harel; Stephen M Strittmatter
Journal:  Ann Neurol       Date:  2007-07       Impact factor: 10.422

Review 3.  Use of biomarkers in ALS drug development and clinical trials.

Authors:  Nadine Bakkar; Ashley Boehringer; Robert Bowser
Journal:  Brain Res       Date:  2014-10-24       Impact factor: 3.252

4.  Severe muscle wasting and denervation in mice lacking the RNA-binding protein ZFP106.

Authors:  Douglas M Anderson; Jessica Cannavino; Hui Li; Kelly M Anderson; Benjamin R Nelson; John McAnally; Svetlana Bezprozvannaya; Yun Liu; Weichun Lin; Ning Liu; Rhonda Bassel-Duby; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-14       Impact factor: 11.205

Review 5.  The "dying-back" phenomenon of motor neurons in ALS.

Authors:  Michal Dadon-Nachum; Eldad Melamed; Daniel Offen
Journal:  J Mol Neurosci       Date:  2010-11-07       Impact factor: 3.444

6.  Early gene expression changes in skeletal muscle from SOD1(G93A) amyotrophic lateral sclerosis animal model.

Authors:  Gabriela P de Oliveira; Jessica R Maximino; Mariana Maschietto; Edmar Zanoteli; Renato D Puga; Leandro Lima; Dirce M Carraro; Gerson Chadi
Journal:  Cell Mol Neurobiol       Date:  2014-01-18       Impact factor: 5.046

7.  Reticulon-4A (Nogo-A) redistributes protein disulfide isomerase to protect mice from SOD1-dependent amyotrophic lateral sclerosis.

Authors:  Yvonne S Yang; Noam Y Harel; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2009-11-04       Impact factor: 6.167

Review 8.  Prognostic factors in ALS: A critical review.

Authors:  Adriano Chiò; Giancarlo Logroscino; Orla Hardiman; Robert Swingler; Douglas Mitchell; Ettore Beghi; Bryan G Traynor
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

Review 9.  Biomarkers in amyotrophic lateral sclerosis: facts and future horizons.

Authors:  Pierre-François Pradat; Michel Dib
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

10.  Conditional Overexpression of rtn4al in Muscle of Adult Zebrafish Displays Defects Similar to Human Amyotrophic Lateral Sclerosis.

Authors:  Cheng-Yung Lin; Po-Hsiang Zhang; You-Jei Chen; Chia-Lun Wu; Huai-Jen Tsai
Journal:  Mar Biotechnol (NY)       Date:  2018-11-15       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.